May 29, 2025

HHS Questions Pediatric Gender Treatment Evidence

HHS review finds weak evidence for puberty blockers, hormones in minors with gender dysphoria, urges protocol updates.

Conexiant

May 29, 2025

Docs Advised to Offer Chaperones for Exams 

A new policy urges physicians to offer chaperones during adolescent exams, emphasizing shared decision-making and trauma-informed care to support patient comfort and clinician protection.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 15, 2025

Assistant Professor Salary Gaps Persist Nationwide

Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.

Conexiant

October 08, 2024

Education for Gen Alpha and Z on Social Media and Cosmetic Dermatology Trends

A recent study reveals the alarming rise of body dysmorphic disorders among adolescents from Generations Alpha and Z, attributing it to the influence of social media and celebrity comparisons. Clinics in Dermatology presents strategies to address these issues.

Conexiant

September 23, 2024

Physicians Urged to Scrutinize Employers Beyond Salary

Beyond salary and work-life balance, physicians seeking new roles should evaluate potential employers' governance, reward systems, and culture, according to a viewpoint published in JAMA Internal Medicine.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

June 26, 2024

FDA Releases Guidance for Drugmakers on Diversity in Clinical Studies

The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.

Conexiant